Introduction to CGT Beyond CAR T-Cell Therapy for Statisticians and Data Scientists

Conference: ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop 2024
09/26/2024: 1:15 PM - 2:30 PM EDT
Parallel 

Description

CAR T-cell therapy is used as a motivating example in many cases. However, there are a multitude of other cell and gene therapies that bring their own considerations. In this session, we will briefly introduce other types of cell and gene therapies, for example NK cell therapies, AAV gene therapy and gene editing technology, that may have different manufacturing, administration, toxicity profiles, and long term follow up requirements. Statisticians and data scientists should have keen awareness of the aspects of various therapies to be best equipped to serve and advise in our roles. We will also briefly highlight the study designs that have been used historically.

Keywords

cell therapy

gene therapy

cell and gene therapy

CGT 

Presenting Author

James Whitmore, Kite Pharma